CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
Journal: Journal of Clinical Investigation
Published: 2020-05-01
DOI: 10.1172/jci131133
Affiliations: 19
Go to articleJournal: Journal of Clinical Investigation
Published: 2020-05-01
DOI: 10.1172/jci131133
Affiliations: 19
Go to article